Navigation Links
BGI reports pig parasite's genomic sequence provides new clues for parasitic diseases research
Date:10/28/2011

itic and free-living roundworms to understand the parasitism-related genetic factors of A. suum and its closely related species A. lumbricoides which causes human infections. In particular, many molecules and proteins identified have seemed to be involved in the invasion of host tissue and regulation with the host immune system. They predicted the secretome of A. suum to comprise 775 proteins with diverse functions and found the A. suum secretome (about 750 molecules) is rich in peptidases linked to the penetration and degradation of host tissues. Some members of the A. suum secretome may play an important role in host-tissue degradation and others are predicted to direct or evade immune responses.

"We also identified a number of potential drug targets. Notably, in the A. suum gene set, we found a homologue (acr-23) of the C. elegans monepantel receptor, suggesting that this drug may kill A. suum. By sequencing A. suum genome, we identified abundant key information to better understand the molecular biology of A. suum and the exquisite complexities of the hostparasite interactions on an immunobiological level. We believe our work will pave the way for the future Parasitic Diseases Research." said Liu.

"Each year, ascariasis affects billions of people and animals worldwide, so it is now crucial to understand its pathogenic mechanism by genomic and post-genomic approaches. In this study, we have more interesting findings, which can provide new hope for the discovery of intervention strategies, with major implications for improving global health." said Bo Li, the co-leading author of the study and Leader of Comparative Genomics Group.


'/>"/>
Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Aware, Inc. Reports Third Quarter 2011 Financial Results
2. Extreme melting on Greenland ice sheet, reports CCNY team
3. Study reports predictors of poor hand hygiene in an emergency department
4. Reports highlight the evolving role of clinical microbiology laboratories
5. ReportsnReports - Biochips Market, Nuclear Medicine Market, Medical Imaging Market Research
6. Aware, Inc. Reports Second Quarter 2011 Financial Results
7. GEN reports on nanotechologys impact on mass spectrometry
8. Announcing Cell Reports -- a new open-access journal from Cell Press
9. Aware, Inc. Reports Second Quarter 2011 Financial Results
10. For the first time, the European IVF Monitoring Group reports on cycles using frozen eggs
11. Mary Ann Liebert Inc. publishers reports upward trend in impact factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... a long time that some creatures evolve more quickly ... plants. But it may be that height plays a ... the U. S. National Evolutionary Synthesis Center. , ... the journal Nature Communications , Lanfear and colleagues ... from a database of global patterns in plant height ...
(Date:5/21/2013)... class of pharmaceuticals can both prevent and treat Alzheimer,s ... "TSPO ligands," are currently used for certain types of ... ligand in young adult mice when pathology was at ... was quite severe," said lead researcher Christian Pike of ... measures of pathology and improved behavior at both ages." ...
(Date:5/21/2013)... of Medicine will study gender differences in how the heart ... and how changes in fat metabolism play a role in ... the National Heart, Lung and Blood Institute. , When stressed, ... changes may play a major role in the development of ... E. Douglas Lewandowski, director of the UIC Center for Cardiovascular ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2
... Researchers at New York University,s Courant Institute of Mathematical ... DNA that simplifies nanocomputingcomputation at the molecular level. Co-authored ... Inside DNA: A Simplifying Framework for Nanocomputing (Morgan and ... from which instructions can be peeled away one at ...
... , New Rochelle, NY, May 16, 2011Ongoing, intrinsic brain ... of energy used by the human brain. This surprising ... and its function, structure, and organization, are described in ... groundbreaking new neuroscience journal Brain Connectivity , a ...
... stem cells of plants could eventually lead to learning how ... to Dr. Xiuren Zhang, Texas AgriLife Research scientist and professor ... of a nearly three-year project led by an AgriLife Research ... one of the most cited scientific peer-review journals in the ...
Cached Biology News:NYU researchers outline method for DNA computation in new book 2AgriLife Research scientists work with RNA silencing and plant stem cells 2
(Date:5/22/2013)... (PRWEB) May 22, 2013 ... sound therapy for tinnitus treatment. AudioNotch is pleased ... . With clinic locations in both British Columbia ... of audiology and hearing services. AudioNotch's tinnitus treatment ... , Upon entering a Destination Hearing clinic, patients ...
(Date:5/22/2013)... 22, 2013 Envera announced today that ... Mr. McErlean has an extensive background in cell ... throughout his career. , Mike Matheny, President ... to have Mike join our team”. “Mike’s background is ... fermentation and downstream processing equipment”, added Matheny. ...
(Date:5/21/2013)... May 22, 2013 First patients ... of glycopyrronium bromide designed using Prosonix, particle engineering platform ... a portfolio of inhaled Respiratory Medicines by Design ... PSX1002 that will assess its effect on lung function ... patients with moderate to severe chronic obstructive pulmonary disease ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Through science ... and funds for lab equipment, 25 organizations will continue ... importance of optics and photonics in daily life with ... , The organizations, located in 10 countries, are the ... be awarded by SPIE, the international society for ...
Breaking Biology Technology:AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Envera Appoints Michael McErlean Fermentation Manager 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3
... DIEGO, Sept. 2 Halozyme Therapeutics,Inc. (Nasdaq: ... and,commercializing products targeting the extracellular matrix, today,announced ... President,Research, Michael J. LaBarre, PhD, Vice President, ... Legal., "Halozyme is committed to attracting, ...
... licenses ... STAMFORD, Conn., Sept. 2 Purdue Pharma L.P. ... to end the OxyContin(R) (oxycodone HCl controlled-release) Tablets,patent infringement ... the Southern District of New York., According to ...
... Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that ... the Company is initiating a U.S.,Phase 2 ... in,combination with paclitaxel and carboplatin in patients ... or EGFR-activated tumours. The Principal,Investigator is Dr. ...
Cached Biology Technology:Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives 2Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives 3Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives 4Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc. 2Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours 2Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours 3Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours 4
... Tecans state-of-the-art software for all your biopharmaceutical ... in a single, scalable software package. The ... simplifying the control of all Freedom instruments ... EVO 100 with one liquid handling arm ...
...
... The Synaptic Vesicles Isolation Kit provides ... an enriched synaptic vesicle fraction. The ... lysis of the synaptosomes, and differential ... gradient. The kit also contains an ...
... hybridization incubators with rotators. Graduated, 35 ... PP plug-seal screw-cap with O-ring for ... lengths to accept different size hybridization ... available separately. • Comp Dim: tube ...
Biology Products: